Bayer: all 1,694 studies
Page 10 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Human Photoallergy TestCompletedNCT02751515Not applicable
- Human Phototoxicity TestCompletedNCT02751489Not applicable
- 18850 - Human Photoallergy TestCompletedNCT02751463Not applicable
- 18794 - Human Photo Toxicity TestCompletedNCT02751372Not applicable
- 18793 - Human Photoallergy TestCompletedNCT02750488Not applicable
- Human Phototoxicity TestCompletedNCT02750475Not applicable
- Human Photoallergy TestCompletedNCT02750449Not applicable
- EPID Multiple Sclerosis Pregnancy StudyCompletedNCT02749396
- Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid TumorsCompletedNCT02746081Phase 1
- Phase I Trial of BAY1251152 for Advanced Blood CancersCompletedNCT02745743Phase 1
- A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active CancerCompletedNCT02742623
- 18750-Sun Protection Factor AssayCompletedNCT02741466Not applicable
- 18751-Sun Protection Factor Assay.CompletedNCT02739802Not applicable
- Pilot Study to Assess Number of Patients for Main TrialCompletedNCT02734628Phase 4
- Treatment Patterns in Metastatic Prostate CancerCompletedNCT02729103
- Evaluation of the Irritation Potential of Products in Human Eyes.CompletedNCT02728856Not applicable
- Exploratory Study for Allergy Relief OnsetTerminatedNCT02722083Phase 2
- 18841- Sun Protection Factor AssayCompletedNCT02717351Not applicable
- 18842 - Sun Protection Factor AssayCompletedNCT02717325Not applicable
- Evaluation of the Irritation Potential of Products in Human EyesCompletedNCT02714166Not applicable
- YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in ChinaCompletedNCT02710708Phase 4
- Second Primary Cancers in Patients With Castration Resistant Prostate CancerCompletedNCT02702908
- Phase I Study of Anetumab Ravtansine in Hepatic or Renal ImpairmentCompletedNCT02696642Phase 1
- 18790 - Sun Protection Factor AssayCompletedNCT02695303Not applicable
- Real-world Comparative Effectiveness of Rivaroxaban Versus VKACompletedNCT02690155
- Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K AntagonistCompletedNCT02687867
- Real-world Comparative Effectiveness of Apixaban Versus Vitamin K AntagonistCompletedNCT02687854
- A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and InstabilityCompletedNCT02682654Not applicable
- 18791 - Sun Protection Factor AssayCompletedNCT02682628Not applicable
- Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe SubstrateCompletedNCT02671097Phase 1
- Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using PlaceboCompletedNCT02661438Not applicable
- Stivarga Real Life Evidence in HungaryCompletedNCT02656524
- Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient SatisfactionCompletedNCT02652091
- Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein OcclusionCompletedNCT02645747
- Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid TumorsCompletedNCT02639091Phase 1
- A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenActive, not recruitingNCT02637687Phase 1/2
- A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA CountriesCompletedNCT02637050
- Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease PatientsCompletedNCT02617550Phase 1
- To Investigate Efficacy of YAZ in the Treatment of DysmenorrheaWithdrawnNCT02617537Phase 3
- HCC Patient Preferences in JapanCompletedNCT02616692
- Burden of Illness in Atrial FibrillationCompletedNCT02615587
- Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductCompletedNCT02615561Not applicable
- Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for AfliberceptCompletedNCT02615496
- Atrial Fibrillation Patient Preference StudyCompletedNCT02611635
- Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control StrategiesCompletedNCT02610153
- Anticoagulation Preference by AF Patients StudyCompletedNCT02607371
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' PatientsCompletedNCT02606864Phase 1
- Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple MyelomaWithdrawnNCT02605356Phase 1/2
- To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach SyrupCompletedNCT02593747Phase 1
- Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid TumorsCompletedNCT02592785Phase 1
- Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in CanadaCompletedNCT02585401
- A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With HypertensionCompletedNCT02585076
- Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."CompletedNCT02581969
- Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's LymphomaCompletedNCT02581878Phase 1
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsCompletedNCT02576431Phase 2
- Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)CompletedNCT02576002
- An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive MethodCompletedNCT02574715
- A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without InhibitorsCompletedNCT02571569Phase 1
- Inhalation Flow Rate-studyCompletedNCT02563197Phase 1
- An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care CentersCompletedNCT02559232
- Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)CompletedNCT02558465
- Interaction With HIV Antiretroviral AgentsCompletedNCT02556268Phase 1
- Special Drug Use Investigation of Ciproxan Injection in PediatricsCompletedNCT02555059
- Russia/Ukraine Suppression of Ovarian Activity StudyCompletedNCT02550977Phase 2
- Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)CompletedNCT02550717
- Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times DailyCompletedNCT02549469Phase 1
- A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical PracticeCompletedNCT02545465
- Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal RingCompletedNCT02545452Phase 1
- Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in JapanCompletedNCT02541084
- Drug Use Investigation of Gadovist.CompletedNCT02540967
- To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.CompletedNCT02540369
- Relative Bioavailability of Sorafenib Tablet for Oral SuspensionCompletedNCT02538393Phase 1
- Bioequivalence Study of RivaroxabanCompletedNCT02537457Phase 1
- Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male SubjectsCompletedNCT02537405Phase 1
- Electronic Activity Level Monitoring Pilot in Pulmonary HypertensionCompletedNCT02536534
- Atrial Fibrillation Screening With a Smartphone Device and iECG ApplicationWithdrawnNCT02534532
- Proportion of Hysterectomy After Female SterilizationCompletedNCT02532361
- Retrospective Claims Analysis of Hysterectomy After SterilizationCompletedNCT02527278
- Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare PopulationCompletedNCT02518698
- Observational Study on Contraception With Essure in FranceCompletedNCT02510443
- Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in ChildrenCompletedNCT02497716Phase 1
- To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further DevelopmentTerminatedNCT02490774Phase 2
- Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With BetaferonCompletedNCT02486640
- Real-Life Evidence on Stroke Prevention in SPAFCompletedNCT02485873
- Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced MalignanciesCompletedNCT02485119Phase 1
- Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and AdvateCompletedNCT02483208Phase 1
- Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and DysmenorrheaCompletedNCT02475356
- An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care CentresCompletedNCT02470767
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)CompletedNCT02468102
- Assess Safety and Efficacy of Vilaprisan in Patients With Uterine FibroidsCompletedNCT02465814Phase 2
- Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal CancerCompletedNCT02465502Phase 2
- Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) StudyCompletedNCT02457351Phase 1
- Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]VilaprisanCompletedNCT02456129Phase 1
- Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)TerminatedNCT02455297Phase 2
- A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular DysfunctionCompletedNCT02452515Phase 2
- Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in GermanyCompletedNCT02450812
- Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone LesionsCompletedNCT02442063Phase 1
- Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous DocetaxelTerminatedNCT02439346Phase 1
- Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy WomenCompletedNCT02434640Phase 1
- Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)CompletedNCT02428985